Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Negotiating Potential $1 Billion Sale Of Two Thrombosis Drugs To Aspen

19 Jun 2013

• By Sten Stovall

Related Content

Only <em>Alli</em> Remains After Glaxo’s OTC Transaction With Aspen

23 Apr 2012

Omega Pharma Acquires Six Glaxo OTC Brands, But <em>Alli</em> Lingers

19 Mar 2012

Prestige Acquires 17 Glaxo OTC Brands, Enters Analgesics Market

02 Jan 2012

GSK Takes Pay-As-You Go Approach In Aspen Branded Generics Deal

28 Jul 2008

Sales & Earnings In Brief

11 Feb 2013

Related Companies

GSK plc

Aspen Pharmacare Holdings Limited

Prestige Consumer Healthcare Inc.

Omega Pharma NV

Additional Topics

South Africa Middle East and Africa United Kingdom Europe Deals Business Strategies Emerging Markets BioPharmaceutical

More from United Kingdom

More from Europe

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.